At enrollment, ERA patients under treatment with low-dose of steroid did not differ in terms of OPG, DKK1, or RANKL plasma levels compared with free of steroid treatment ERA patients (data not shown). This evidence concerns the gene TNFSF11 and enthesitis-related juvenile idiopathic arthritis.